The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: Results from a two-year controlled prospective study

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2709-2715

  Audí, Laura ^a,d   Carrascosa, A ^a   Esteban, C ^a   Fernandez Cancio M ^a   Andaluz, P ^a   Yeste, D ^a   Espadero, R ^b   Granada, M L ^c   Wollmann, H ^b   Fryklund, L ^b   Ajram, J ^e   Aragones, A ^e   Arroyos, A ^e   Balaguer, A ^e   Ballester, M J ^e   Bel, J ^e   Borras M V ^e   Bosch, J ^e   Cabrinety, N ^e   Caimari M ^e   Camprubi M ^e   Cantero, P ^e   Canete R ^e   Cao, G ^e   Carreras, G ^e   Corripio, R ^e   De Ureta, A ^e   Del Valle, C J ^e   Espigares, R ^e   Feliu, A ^e   Fernandez C ^e   Ferragut, J ^e   Ferrandez A ^e   Ferrer, A ^e   Gallego, M E ^e   Gomez A ^e   Gonzalez J P ^e   Gracia, R ^e   Grau, G ^e   Gussinye M ^e   Gutierrez, P ^e   Herraez M T ^e   Ibanez L ^e   Labarta, J I ^e   Lechuga, J L ^e   Lledo G ^e   Llusa A ^e   Lopez R ^e   Lopez Siguero J P ^e   Lorenzo, L ^e   Luzuriaga, C ^e   Mainou, A ^e   Marcos, M V ^e   Martinez Aedo M J ^e   Martul, P ^e   Mayayo, E ^e   Montesdeoca, A ^e   Nosas, R ^e   Oliver, A ^e   Pisonero, M J ^e   Pons, N ^e   Rial, J M ^e   Rica, I ^e   Rite, S ^e   Rodrigo, J ^e   Rodriguez Hierro F ^e   Rodriguez A ^e   Rodriguez I ^e   Romo, A ^e   Sanchez Del Pozo J ^e   Sastre, E ^e   Sinues B ^e   Sobradillo, B ^e   Tacons, J ^e   Vela, A ^e   Vicens Calvet, E ^e   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b PFIZER INC   (United States)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^e Pfizer Health AB ^*

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN;

ARTICLE; BODY HEIGHT; BODY MASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; EVALUATION; EXON; EXON 3 DELETED GENE FULL LENGTH GENE; FEMALE; GENE DELETION; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; SMALL FOR DATE INFANT;

EID: 47549090085     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0150     Document Type: Article

References (44)

1. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
2. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
3. Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659-664
4. Carrascosa A, Esteban C, Espadero R, Fernandez-Cancio M, Andaluz P, Clemente M, Audi L, Wollmann H, Fryklund L, Parodi L 2006 The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 μg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. J Clin Endocrinol Metab 91:3281-3286
5. Tauber M, Ester W, Auriol F, Molinas C, Fauvel J, Caliebe J, Nugent T, Fryklund L, Ranke MB, Savage MO, Clark AJ, Johnston LB, Hokken-Koelega AC 2007 GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism. Clin Endocrinol (Oxf) 67:457-461
6. Carrascosa A, Audi L, Esteban C, Fernandez-Cancio M, Andaluz P, Gussinye M, Clemente M, Yeste D, Albisu MA 2008 Growth hormone dose, but not exon 3-deleted/full-length growth hormone receptor polymorphism genotypes, influences growth response to two-year growth hormone therapy in short small-for-gestational-age children. J Clin Endocrinol Metab 93:147-153
7. Carrascosa A, Audí L, Fernández-Cancio M, Esteban C, Andaluz P, Vilaró E, Clemente M, Yeste D, Albisu MA, Gussinyé M 2008 The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. J Clin Endocrinol Metab 93:764-770
8. Audi L, Esteban C, Carrascosa A, Espadero R, Perez-Arroyo A, Arjona R, Clemente M, Wollmann H, Fryklund L, Parodi LA 2006 Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n-= 247) and in an adult control population (n-289) show increased fl/fl in short SGA. J Clin Endocrinol Metab 91:5038-5043
9. Schreiner F, Stutte S, Bartmann P, Gohlke B, Woelfle J 2007 Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams. J Clin Endocrinol Metab 92:4489-4493
10. Mericq V, Roman R, Iniguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F 2007 Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children. Horm Res 68:132-138
11. Strawbridge RJ, Karvestedt L, Li C, Efendic S, Ostenson CG, Gu HF, Brismar K 2007 GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm IGF Res 17:392-398
12. Crowther NJ, Cameron N, Trusler J, Gray IP 1998 Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia 41:1163-1167
13. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA 2002 Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 87:4657-4661
14. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K 1996 Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 81:3902-3908
15. Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 1999 Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 84:3064-3070
16. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ 1999 Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 318:427-431
17. Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P 2006 Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Horm Res 65(Suppl 3):153-159
18. Rosenfeld RG, Wilson DM, Dollar LA, Bennett A, Hintz RL 1982 Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 54:1033-1038
19. Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE 1999 Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 84:1658-1663
20. Arslanian SA, Kalhan SC 1994 Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes 43:908-914
21. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV 1989 Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114:963-967
22. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
23. Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L 2003 Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 88:1455-1463
24. Carrascosa A, Yeste D, Copil A, Almar J, Salcedo S, Gussinye M 2004 [Anthropometric growth patterns of preterm and full-term newborns (24-42 weeks' gestational age) at the Hospital Materno-Infantil Vall d'Hebron (Barcelona)(1997-2002]. An Pediatr (Barc) 60:406-416 (Spanish)
25. Carrascosa A, Yeste D, Copil A, Gussinye M 2004 [Secular growth changes. Weight, height and body mass index values in infant, children, adolescent and young adults from Barcelona population]. Med Clin (Barc) 123:445-451 (Spanish)
26. Ferrández-Longas AF, Baguer L, Labarta JI, Labena C, Mayayo E, Puga B, Rueda C, Ruiz-Echarri M 2005 Longitudinal study of normal Spanish children from birth to adulthood anthropometric, puberty, radiological and intellectual data. Pediatr Endocrinol Rev 2(Suppl 4):425
27. Carrascosa A, Audi L, Bosch-Castañé J, Gussinye M, Yeste D, Albisu MA, Clemente M, Ferrández-Longas AF, Baguer L, Influence of the age at the start of pubertal growth on adult height. Med Clin (Barc) 130:645-649
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
29. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
30. Yeste D, Vendrell J, Tomasini R, Broch M, Gussinye M, Megia A, Carrascosa A 2007 Interleukin-6 in obese children and adolescents with and without glucose intolerance. Diabetes Care 30:1892-1894
31. Audí L, Llopis MA, Granada ML, Hermoso F, del Valle J, Rodríguez-Arnao MD, Bel J, Luzuriaga C, Gallego E, Marín F; Grupo Español de Estudio de la Talla Baja 2001 Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Med Clin (Bar) 116: 6-11
32. Potau N, Gussinye M, Sanchez Ufarte C, Rique S, Vicens-Calvet E, Carrascosa A 2001 Hyperinsulinemia in pre- and post-pubertal children born small for gestational age. Horm Res 56:146-150
33. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA 2002 Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 25:2081-2087
34. Gungor N, Saad R, Janosky J, Arslanian S 2004 Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47-55
35. Hoffman RP, Vicini P, Cobelli C 2004 Pubertal changes in HOMA and QUICKI: relationship to hepatic and peripheral insulin sensitivity. Pediatr Diabetes 5:122-125
36. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB, Mericq MV 2003 Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 88:3645-3650
37. Ghirri P, Ladaki C, Bartoli A, Scire G, Vuerich M, Spadoni GL, Maiorana A, Geremia C, Boldrini A, Cianfarani S 2007 Low birth weight for gestational age associates with reduced glucose concentrations at birth, infancy and childhood. Horm Res 67:123-131
38. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M 2005 Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem 61:381-388
39. Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2001 Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf) 54:243-251
40. de Zegher F, Ong K, van Helvoirt M, Mohn A, Woods K, Dunger D 2002 High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 87:148-151
41. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2003 Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 88:3584-3590
42. van Dijk M, Bannink EM, van Pareren YK, Mulder PG, Hokken-Koelega AC 2007 Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J Clin Endocrinol Metab 92:160-165
43. Sas T, Mulder P, Hokken-Koelega A 2000 Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab 85:3786-3792
44. Binder G, Trebar B, Baur F, Schweizer R, Ranke MB 2007 Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome. Clin Endocrinol (Oxf) 68:567-572